HomeCompaniesProfile

Engage Bio

Potent, durable, and redosable non-viral genetic medicines 

Company Size

6 - 10 employees

Year Founded

2021

About Engage Bio

Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine.

In 2026 Engage was acquired by Eli Lilly.

Founders & Key People

Kathryn Kwant

Kathryn Kwant

Founder, Engage Bio

Will Olsen

Will Olsen

Founder, Engage Bio

Share This Profile

More Companies

zeroheight

The design system layer for coding agents

Clear Gene

Our tests help eradicate cancer by telling doctors whether they got…

CoVerified

Using infection data to keep organizations safe

Baubap

Smart micro financing for everyone

Waterplan

Water risk mitigation for industrial sites

Glimpse

Glimpse is the system of action for CPG retail operations

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Connect with Us

Discover More

© Copyright 2026 BEAMSTART. All Rights Reserved.